Healthtech Public Comp Sheet and Valuation Guide Summary
Core Content
This document provides an analysis of the public healthtech sector, focusing on stock returns, valuations, revenue, and EBITDA for various segments. It highlights key trends, challenges, and opportunities within the industry as of March 31, 2025.
Key Takeaways
- Market Decline Impact: The majority of public healthtech shares declined in Q1, reflecting broader market downturns. However, the benefit management & care navigation segment showed resilience, with Claritev and Progyny experiencing significant price increases of 58% and 26%, respectively.
- Tariff Impact: The Trump Administration's recent tariff announcements have caused market volatility, affecting IPO prospects. This has raised concerns about liquidity in the healthtech VC ecosystem and the potential for more down rounds for aging startups.
- Take-Privates: Two notable take-privates occurred in Q1: Transcarent acquired Accolade at $621 million, a 100% premium over its pre-announcement share price, and Nexus was sold to TA Associates Management for $1.3 billion.
- 23andMe Delisting: After years of financial and strategic issues, 23andMe filed for bankruptcy and was delisted from Nasdaq. The company had previously reached a valuation of $6 billion through a SPAC merger but has since seen a steady decline, with a current pursuit of a sale.
Stock Returns
Provider Operations & Revenue Cycle
| Company |
Ticker |
1 week |
30 days |
90 days |
Bottom |
YTD |
1 year |
3 years |
5 years |
| Cegedim |
PAR: CGM |
-9% |
-9% |
-5% |
-13% |
-8% |
-10% |
-55% |
-52% |
| Definitive Healthcare |
NAS: DH |
-3% |
-11% |
-30% |
-79% |
-30% |
-64% |
-88% |
N/A |
| Doximity |
NYS: DOCS |
3% |
7% |
19% |
14% |
20% |
-9% |
37% |
86% |
| Gruppo GPI |
MIL: GPI |
0% |
3% |
-16% |
-19% |
-12% |
-27% |
-39% |
31% |
| HealthStream |
NAS: HSTM |
0% |
-5% |
1% |
53% |
1% |
21% |
62% |
34% |
| Omnicell |
NAS: OMCL |
-1% |
-8% |
-21% |
-54% |
-21% |
20% |
-73% |
-47% |
| Phreesia |
NYS: PHR |
-9% |
-4% |
2% |
6% |
1% |
7% |
-3% |
22% |
| Premier |
NAS: PINC |
1% |
6% |
-9% |
-41% |
-10% |
-13% |
-46% |
-41% |
| Streamline Health Solutions |
NAS: STRM |
-14% |
-24% |
-26% |
-84% |
-23% |
-61% |
-88% |
-78% |
| Waystar Health |
NAS: WAY |
-4% |
-14% |
2% |
N/A |
4% |
N/A |
N/A |
N/A |
| Mean |
-3% |
-6% |
-8% |
-24% |
-8% |
-15% |
-33% |
-6% |
|
| Median |
-2% |
-6% |
-7% |
-19% |
-9% |
-10% |
-46% |
-10% |
|
Benefit Management & Care Navigation
| Company |
Ticker |
1 week |
30 days |
90 days |
Bottom |
YTD |
1 year |
3 years |
5 years |
| Accolade |
NAS: ACCD |
0% |
0% |
104% |
-40% |
104% |
-33% |
-60% |
N/A |
| GoHealth |
NAS: GOCO |
-9% |
-15% |
-8% |
132% |
-12% |
17% |
-31% |
N/A |
| HealthEquity |
NAS: HQY |
-2% |
-19% |
-8% |
28% |
-9% |
8% |
31% |
75% |
| Claritev |
NYS: CTEV |
-3% |
-2% |
40% |
-81% |
59% |
-36% |
-89% |
N/A |
| Progyny |
NAS: PGNY |
1% |
-1% |
30% |
-42% |
26% |
-41% |
-57% |
5% |
| Mean |
-3% |
-7% |
31% |
-1% |
34% |
-17% |
-41% |
-41% |
|
| Median |
-2% |
-2% |
30% |
-40% |
26% |
-33% |
-57% |
40% |
|
EHRs & Clinical Information
| Company |
Ticker |
1 week |
30 days |
90 days |
Bottom |
YTD |
1 year |
3 years |
5 years |
| Consensus Cloud Solutions |
NAS: CCSI |
-7% |
-12% |
-3% |
-54% |
-4% |
46% |
-62% |
N/A |
| Health Catalyst |
NAS: HCAT |
2% |
-3% |
-36% |
-49% |
-38% |
-40% |
-83% |
-83% |
| HEALWELL AI |
TSE: AIDX |
-10% |
2% |
-28% |
53% |
-27% |
54% |
-3% |
N/A |
| Nordhealth |
OSL: NORDH |
-1% |
2% |
-7% |
122% |
-2% |
27% |
27% |
N/A |
| Oneview Healthcare |
ASX: ONE |
-4% |
-15% |
3% |
151% |
3% |
-11% |
14% |
664% |
| Sectra |
STO: SECT B |
-5% |
9% |
-5% |
117% |
-6% |
23% |
53% |
220% |
| TruBridge |
NAS: TBRG |
-6% |
-5% |
40% |
0% |
38% |
198% |
-20% |
24% |
| Veradigm |
PINX: MDRX |
3% |
-15% |
-55% |
-69% |
-52% |
-43% |
-81% |
-38% |
| VitalHub |
TSE: VHI |
10% |
1% |
-10% |
301% |
-7% |
60% |
188% |
634% |
| Mean |
4.0x |
3.7x |
6.5x |
4.5x |
3.9x |
4.7x |
1.6x |
|
|
| Median |
2.2x |
2.1x |
4.4x |
3.5x |
3.5x |
4.1x |
0.8x |
|
|
Virtual Care & RPM
| Company |
Ticker |
1 week |
30 days |
90 days |
Bottom |
YTD |
1 year |
3 years |
5 years |
| Amwell |
NYS: AMWL |
-3% |
-21% |
9% |
-89% |
12% |
-51% |
-91% |
N/A |
| DarioHealth |
NAS: DRIO |
-13% |
-12% |
-22% |
-88% |
-25% |
-60% |
-90% |
-91% |
| DocGo |
NAS: DCGO |
-5% |
-15% |
-38% |
-76% |
-38% |
-35% |
-71% |
N/A |
| iRhythm Technologies |
NAS: IRTC |
-1% |
-5% |
16% |
-13% |
-17% |
-10% |
-34% |
29% |
| Kooth |
LON: KOO |
-11% |
3% |
10% |
159% |
-23% |
-48% |
-45% |
N/A |
| LifeMD |
NAS: LFMD |
-1% |
-15% |
-10% |
43% |
-18% |
-28% |
47% |
N/A |
| LifeStance Health |
NAS: LFST |
-32% |
-60% |
-89% |
-99% |
-89% |
-94% |
-99% |
-98% |
| Modivcare |
NAS: MODV |
-10% |
-17% |
-12% |
-68% |
-16% |
-47% |
-89% |
-95% |
| Talkspace |
NAS: TALK |
-8% |
-16% |
-18% |
-5% |
-19% |
-41% |
-45% |
-91% |
| Teladoc Health |
NYS: TDOC |
-7% |
-13% |
-15% |
43% |
-17% |
-47% |
54% |
419% |
| Mean |
5.3x |
3.7x |
6.6x |
3.4x |
3.4x |
3.7x |
1.6x |
|
|
| Median |
5.3x |
5.4x |
5.8x |
3.5x |
3.5x |
2.9x |
0.8x |
|
|
Valuations
EV/LTM Revenue
EV/LTM EBITDA
Revenue
Provider Operations & Revenue Cycle
| Company |
Ticker |
Enterprise Value ($B) |
| Cegedim |
PAR: CGM |
$0.5 |
| Definitive Healthcare |
NAS: DH |
$0.5 |
| Doximity |
NYS: DOCS |
$10.1 |
| Gruppo GPI |
MIL: GPI |
$0.6 |
| HealthStream |
NAS: HSTM |
$0.9 |
| Omnicell |
NAS: OMCL |
$1.6 |
| Phreesia |
NYS: PHR |
$1.4 |
| Premier |
NAS: PINC |
$1.8 |
| Streamline Health Solutions |
NAS: STRM |
$0.0 |
| Waystar Health |
NAS: WAY |
$7.5 |
| Sum |
- |
$24.9 |
Benefit Management & Care Navigation
| Company |
Ticker |
Enterprise Value ($B) |
| Accolade |
NAS: ACCD |
$0.6 |
| GoHealth |
NAS: GOCO |
$0.8 |
| HealthEquity |
NAS: HQY |
$8.5 |
| Claritev |
NYS: CTEV |
$4.9 |
| Progyny |
NAS: PGNY |
$1.7 |
| Sum |
- |
$16.4 |
EHRs & Clinical Information
| Company |
Ticker |
Enterprise Value ($B) |
| Consensus Cloud Solutions |
NAS: CCSI |
$1.0 |
| Health Catalyst |
NAS: HCAT |
$0.3 |
| HEALWELL AI |
TSE: AIDX |
$0.2 |
| Nordhealth |
OSL: NORDH |
$0.3 |
| Oneview Healthcare |
ASX: ONE |
$0.1 |
| Sectra |
STO: SECT B |
$4.5 |
| TruBridge |
NAS: TBRG |
$0.6 |
| Veradigm |
PINX: MDRX |
$0.5 |
| VitalHub |
TSE: VHI |
$0.4 |
| Sum |
- |
$1.8 |
Virtual Care & RPM
| Company |
Ticker |
Enterprise Value ($B) |
| Amwell |
NYS: AMWL |
-$0.1 |
| DarioHealth |
NAS: DRIO |
$0.0 |
| DocGo |
NAS: DCGO |
$0.2 |
| iRhythm Technologies |
NAS: IRTC |
$3.5 |
| Kooth |
LON: KOO |
$0.0 |
| LifeMD |
NAS: LFMD |
$0.2 |
| LifeStance Health |
NAS: LFST |
$2.9 |
| Modivcare |
NAS: MODV |
$1.2 |
| Talkspace |
NAS: TALK |
$0.3 |
| Teladoc Health |
NYS: TDOC |
$1.7 |
| Sum |
- |
$3.9 |
EBITDA
Provider Operations & Revenue Cycle
| Company |
Ticker |
Actual EBITDA ($M) |
| Cegedim |
PAR: CGM |
$113.3 |
| Definitive Healthcare |
NAS: DH |
$118.5 |
| Doximity |
NYS: DOCS |
$123.8 |
| Gruppo GPI |
MIL: GPI |
$9.8 |
| HealthStream |
NAS: HSTM |
$26.8 |
| Omnicell |
NAS: OMCL |
$64.8 |
| Phreesia |
NYS: PHR |
$47.2 |
| Premier |
NAS: PINC |
$166.8 |
| Streamline Health Solutions |
NAS: STRM |
$3.5 |
| Waystar Health |
NAS: WAY |
$561.0 |
| Sum |
- |
$935.5 |
Benefit Management & Care Navigation
| Company |
Ticker |
Actual EBITDA ($M) |
| Accolade |
NAS: ACCD |
$53.5 |
| GoHealth |
NAS: GOCO |
$564.0 |
| HealthEquity |
NAS: HQY |
$564.0 |
| Claritev |
NYS: CTEV |
$3.5 |
| Progyny |
NAS: PGNY |
$561.0 |
| Sum |
- |
$935.5 |
EHRs & Clinical Information
| Company |
Ticker |
Actual EBITDA ($M) |
| Consensus Cloud Solutions |
NAS: CCSI |
$113.3 |
| Health Catalyst |
NAS: HCAT |
$118.5 |
| HEALWELL AI |
TSE: AIDX |
$123.8 |
| Nordhealth |
OSL: NORDH |
$9.8 |
| Oneview Healthcare |
ASX: ONE |
$26.8 |
| Sectra |
STO: SECT B |
$64.8 |
| TruBridge |
NAS: TBRG |
$47.2 |
| Veradigm |
PINX: MDRX |
$166.8 |
| VitalHub |
TSE: VHI |
$3.5 |
| Sum |
- |
$935.5 |
Conclusion
The healthtech sector has faced challenges due to market decline and tariff-related volatility. While some companies like Claritev and Progyny have shown resilience, others have struggled with profitability and valuation pressures. The trend of take-privates and delistings reflects the sector's evolving landscape, with a focus on sustainable business models and strategic exits. PitchBook clients have access to comprehensive data packs for deeper analysis.